Cited by 515SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesEvolution and Genetic Dynamics

Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients With Coronavirus Disease 2019

Open access
Shen, Zijie, Xiao, Yan, Kang, Lu, Ma, Wentai, Shi, Leisheng, Zhang, Li, Zhou, Zhuo, Yang, Jing +11 more·2020·Clinical Infectious Diseases

Abstract

Background: A novel coronavirus (CoV), severe acute respiratory syndrome (SARS)–CoV-2, has infected >75 000 individuals and spread to >20 countries. It is still unclear how fast the virus evolved and how it interacts with other microorganisms in the lung. Methods: We have conducted metatranscriptome sequencing for bronchoalveolar lavage fluid samples from 8 patients with SARS–CoV-2, and also analyzed data from 25 patients with community-acquired pneumonia (CAP), and 20 healthy controls for comparison. Results: The median number of intrahost variants was 1–4 in SARS–CoV-2–infected patients, ranged from 0 to 51 in different samples. The distribution of variants on genes was similar to those observed in the population data. However, very few intrahost variants were observed in the population as polymorphisms, implying either a bottleneck or purifying selection involved in the transmission of the virus, or a consequence of the limited diversity represented in the current polymorphism data. Although current evidence did not support the transmission of intrahost variants in a possible person-to-person spread, the risk should not be overlooked. Microbiotas in SARS–CoV-2–infected patients were similar to those in CAP, either dominated by the pathogens or with elevated levels of oral and upper respiratory commensal bacteria. Conclusion: SARS–CoV-2 evolves in vivo after infection, which may affect its virulence, infectivity, and transmissibility. Although how the intrahost variant spreads in the population is still elusive, it is necessary to strengthen the surveillance of the viral evolution in the population and associated clinical changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa203

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metagenomic sequencing of bronchoalveolar lavage fluid among patients with COVID-19 demonstrated an increased presence of oral and upper-respiratory-tract bacteria.

    “metagenomic sequencing of bronchoalveolar lavage fluid among patients with COVID‐19 demonstrated an increased presence of oral and upper‐respiratory‐tract bacteria.”
  • Metatranscriptome sequencing of bronchoalveolar lavage fluid from 8 COVID-19 patients revealed elevated levels of oral and upper respiratory commensal bacteria.

    “Metatranscriptome sequencing for the bronchoalveolar lavage fluid (BALF) of 8 COVID-19 patients revealed the presence of elevated levels of oral and upper respiratory commensal bacteria (Shen et al., 2020).”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Shen et al., 2020

  • Elevated levels of oral commensal bacteria were found from the BALF of COVID-19 patients.

    “with the elevated level of oral commensal bacteria were found from the BALF of COVID-19 patients (Shen et al., 2020)”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Shen et al., 2020

  • A main challenge is the variety of data of a pandemic virus; SARS-CoV-2 mutates over different geographic regions, environments, and time, so a pandemic dataset collected from one region may not work to draw inference on the pandemic of other regions.

    “The second one is the variety of data of a pandemic virus. This COVID-19 virus ‘SARS-CoV-2’ has been mutating itself over different geographic regions, environments, and time [102], [103]. Therefore, the pandemic dataset collected from one region may not be work to drawn inference on the pandemic of other regions.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Camacho C, Coulouris G, Avagyan V, et al. BLAST+: architecture and applica- tions. BMC Bioinformatics 2009; 10:421.

Cited by

Sorted by citations

Authors
Shen, Z., Xiao, Y., Kang, L., Ma, W., Shi, L., Zhang, L., Zhou, Z., Yang, J., Zhong, J., Yang, D., Guo, L., Zhang, G., Li, H., Xu, Y., Chen, M., Gao, Z., Wang, J., Ren, L., & Li, M.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Peking University (CN)
  • Peking University People's Hospital (CN)
  • Southern University of Science and Technology (CN)
  • Fujian Provincial Hospital (CN)
  • First Affiliated Hospital of Xi'an Jiaotong University (CN)
Corresponding author
Li, Mingkun
Venue
Clinical Infectious Diseases
Published
2020-03-09
Volume
71
Issue
15
Pages
713-720
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3009109635
Cited by
513
References
43
Citations by year
2026: 4 · 2025: 8 · 2024: 29 · 2023: 48 · 2022: 86 · 2021: 180 · 2020: 157
FWCI
15.49
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-014)
  • National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases in China (2017ZX10103004, 2018ZX10305409, 2018ZX10301401, 2018ZX1073240)
  • National Natural Science Foundation of China (31670169, 31871263)
  • Open Project of Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
SARS-CoV-2, COVID-19 pandemic, viral evolution, metatranscriptomics, bronchoalveolar lavage fluid, lung microbiome, community-acquired pneumonia, virus transmission, purifying selection, commensal bacteria
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Genetic Variation, Coronavirus, Coronavirus Infections, Genomics, Severe Acute Respiratory Syndrome, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review